Office of the Commissioner of Lobbying of Canada
Registry of Lobbyists

Monthly Communication Report

360616-658450

Organization: Novo Nordisk Canada Inc.
Associated registration: 954988-360616-22
Communication date: 2025-11-21
Posted date: 2025-12-15

Designated Public Office Holders who participated in the communication: Shahad Khalladi, Senior Policy Advisor
Office of the Minister of Health, Health Canada (HC)
 
List of Details
Subject matter Detail
Health, International Trade Communication around existing drug shortages and shared solutions to mitigate the impact on Canadians.
Health, International Trade Free trade agreements as they relate to the biopharmaceutical industry.
 
Communication Report amended on: 2025-11-24 previous entry: 360616-658448
Reason for amendment: Corrected DPOH title.
 
Responsible Officer who filed this communication report: Vince Lamanna
 
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication.

The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.
 

Date Modified: